“Paul is an expert in the field and provides well-reasoned and thoughtful advice that measures risk and opportunity extremely well.”
Chambers USA, Healthcare client
“Paul is an expert in the field and provides well-reasoned and thoughtful advice that measures risk and opportunity extremely well.”
Chambers USA, Healthcare client
Paul advises health care providers and life sciences companies on regulatory matters and business transactions. Clients turn to him for guidance on compliance with fraud and abuse laws, payment and coverage rules, privacy and security laws, and participation in Medicare and Medicaid programs. Paul works with all types of health care and life sciences organizations – from startups to public companies – throughout the lifecycle of a company or an investment. He also serves as managing partner of Reed Smith’s Silicon Valley office.
With a focus on finding practical solutions, Paul advises clients on business and regulatory considerations in strategic transactions and contractual arrangements. He has extensive experience in negotiating and drafting agreements between health care entities, forming joint ventures, advising on investments in startups, and counseling clients on vertically integrated models of care. He has represented buyers and sellers in major acquisitions in the life sciences and health care industry, focusing on due diligence, change of ownership issues, regulatory approvals, risk mitigation, and business integration.
Paul also advises clients on internal investigations, including allegations of false claims or other noncompliance with federal and state law. He has represented all types of health care providers in disclosing and refunding Medicare overpayments and assisted in the defense of false claims investigations brought by the Department of Justice and the Office of Inspector General.
Experience
Representative matters
Served as co-counsel to McKesson Corporation in its agreement with CD&R to acquire Option Care Health, Inc., a national provider of home and alternate site infusion services, at a total enterprise value of $5.8 billion. Under the agreement, McKesson will invest $1.4 billion for a 49% stake and has a framework to later acquire CD&R’s interest.
Advised McKesson on health care and privacy regulatory matters and due diligence in connection with McKesson’s agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services, in a transaction valued at approximately $2.25 billion.
Led complex health care regulatory due diligence for McKesson in its acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC, a leading physician owned community oncology practice.
Representative Experience
Served as co-counsel to McKesson Corporation in its agreement with CD&R to acquire Option Care Health, Inc., a national provider of home and alternate site infusion services, at a total enterprise value of $5.8 billion. Under the agreement, McKesson will invest $1.4 billion for a 49% stake and has a framework to later acquire CD&R’s interest.
Advised McKesson on health care and privacy regulatory matters and due diligence in connection with McKesson’s agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services, in a transaction valued at approximately $2.25 billion.
Led complex health care regulatory due diligence for McKesson in its acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC, a leading physician owned community oncology practice.
Led complex regulatory due diligence for McKesson in its acquisition of a controlling interest in PRISM Vision Holdings LLC, a premier provider of general ophthalmology and retina management services.
Advised clients across the United States on the development and deployment of telemedicine and teleradiology services.
Represented a global health care IT medical-surgical supplies and pharmaceutical distributor as health care regulatory counsel in its acquisition of a national cancer treatment facility network.
Advised practice management companies on all aspects of compliance with restrictions on the corporate practice of medicine, dentistry, and optometry.
Represented radiology groups across the United States in forming and restructuring joint ventures with hospitals and regional health systems involving the operation of outpatient imaging centers and the delivery of professional services.
Advised a hospital in responding to multiple deficiency findings threatening its participation in the Medicare program.
Advised physician practices on participation in a clinically integrated network with a community hospital.
Represented a private equity investor in its acquisition of physician practices; telehealth providers; hospice and home health companies; and residential treatment facilities specializing in eating disorders, substance abuse, and mental health disorders.
Represented physician practices in strategic sales to private equity investors.
Lead health care counsel in the development of a multimillion-dollar oncology center of regional medical center, including the negotiation of physician investment and professional services agreements.
Represented a radiation oncology provider in structuring and closing a joint venture with a regional health care system involving five radiation therapy centers and multiple professional services, management, and IT agreements.
Represented a radiology group in a protracted Medicare appeal concerning alleged overpayments following a probe audit that resulted in a favorable decision that reversed the denials of payments and the requirement for prepayment review.
Provided due diligence for, and health care regulatory guidance to a global investment management firm in connection with its successful investment in a leading LASIK eye surgery company.
Represented Kindred Healthcare in its 2011 $877 million acquisition of RehabCare Group, Inc.
Assisted a client with preparation of offering documents and a private placement memorandum for investment in a New Jersey ambulatory surgical center developed by Meridian Health and United Surgical Partners.
Recognitions
Recognized in the prestigious, client-selected Thomson Reuters Stand-Out Lawyers listing for 2026
Named by The Daily Journal as a Top Health Care Lawyer, 2019, 2023
Ranked in Chambers USA for California Healthcare, 2018-2026
Credentials
Education
Tulane Law School, 2003, J.D.
Tulane University, 2003, MHA (Masters in Health Administration), School of Public Health & Tropical Medicine
Purdue University, 1997, B.A., Political Science, Phi Beta Kappa
Purdue University, 1997, B.S., Business Management
Professional admissions & qualifications
Louisiana
California
Professional affiliations
American Bar Association Health Law Section; Chair of Life Sciences Interest Group
American Bar Association Health Law Section; Former Vice Chair of Life Sciences Interest Group
American Health Lawyers Association; Active Member
California Society for Professionals in Healthcare; Former Board Member
California Society for Healthcare Attorneys; Active Member
Purdue Alumni Association; Life Member, Former Board Member
Radiology Business Management Association; Former Member of Federal Affairs Committee
Women’s Community Clinic; Board Member, 2012-present